Evidence map›Paper›PMID 37036444›Full record

ArticleThe Journal of cell biology2023

Mechanosensitive mTORC1 signaling maintains lymphatic valves.

Cansaran Saygili Demir, Amélie Sabine, Muyun Gong, Olivier Dormond, Tatiana V Petrova

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Developmental progression of lymphatic valve morphology and function.Frontiers in cell and developmental biology · 2024
    Article
  12. Riding up the escaLEC-TOR for valvular health.The Journal of cell biology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Cansaran Saygili Demir *Department of Oncology, Lausanne University Hospital-University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-5665-8184
Amélie Sabine *Department of Oncology, Lausanne University Hospital-University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-7512-6703
Muyun GongDepartment of Oncology, Lausanne University Hospital-University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-3254-9623
Olivier DormondDepartment of Visceral Surgery, Lausanne University Hospital, Lausanne, Switzerland.ORCID 0000-0002-6418-1782
Tatiana V PetrovaDepartment of Oncology, Lausanne University Hospital-University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-0563-6521
Ludwig Cancer Research · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homeostatic maintenance and repair of lymphatic vessels are essential for health. We investigated the dynamics and the molecular mechanisms of lymphatic endothelial cell (LEC) renewal in adult mesenteric quiescent lymphatic vasculature using label-retention, lineage tracing, and cell ablation strategies. Unlike during development, adult LEC turnover and proliferation was confined to the valve regions of collecting vessels, with valve cells displaying the shortest lifespan. Proliferating valve sinus LECs were the main source for maintenance and repair of lymphatic valves. We identified mechanistic target of rapamycin complex 1 (mTORC1) as a mechanoresponsive pathway activated by fluid shear stress in LECs. Depending on the shear stress level, mTORC1 activity drives division of valve cells or dictates their mechanic resilience through increased protein synthesis. Overactivation of lymphatic mTORC1 in vivo promoted supernumerary valve formation. Our work provides insights into the molecular mechanisms of maintenance of healthy lymphatic vascular system.

Indexed as

Lymphatic VesselsMechanistic Target of Rapamycin Complex 1Endothelial CellsHomeostasisLymphangiogenesisSignal TransductionMechanistic Target of Rapamycin Complex 1

Identifiers

PMID37036444
PMCPMC10097975
OpenAlexW4363632303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.